Careful Considerations for Midcrisis Consent to and Refusal of Blood Products
- PMID: 38100801
- DOI: 10.1213/ANE.0000000000006704
Careful Considerations for Midcrisis Consent to and Refusal of Blood Products
Conflict of interest statement
The authors declare no conflicts of interest.
References
-
- Holland E, Richards JL, Langlois WO, et al. Ethical and medicolegal issues: when obstetric patients who refuse blood products change their minds. Anesth Analg. 2024;138:89–95.
-
- Winter L, Parks SM, Diamond JJ. Ask a different question, get a different answer: why living wills are poor guides to care preferences at the end of life. J Palliat Med. 2010;13:567–572.
-
- Messinger-Rapport BJ, Baum EE, Smith ML. Advance care planning: beyond the living will. Cleve Clin J Med. 2009;76:276–285.
-
- Ågård A, Hermerén G, Herlitz J. Patients’ experiences of intervention trials on the treatment of myocardial infarction: is it time to adjust the informed consent procedure to the patient’s capacity? Heart. 2001;86:632–637.
-
- Gammelgaard A, Mortensen OS, Rossel P; DANAMI-2 Investigators. Patients’ perceptions of informed consent in acute myocardial infarction research: a questionnaire based survey of the consent process in the DANAMI-2 trial. Heart. 2004;90:1124–1128.
MeSH terms
LinkOut - more resources
Full Text Sources
